Cell Microarrays for High Throughput RNAi
Award amount
$99,510Program and phase
SBIR · Phase IAward year
2003Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- VL99GKFNM1G3
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Effective Nanoantibodies as Promising Therapeutics for Treating Sepsis
- Human Neural Stem Cells Engineered against oAβ Induced Toxicity for Cell Therapy
- Adaptable and Automated Large-Scale Manufacturing of iPSC-Derived Cell Products
- Anti-RPS23RG1 Nanoantibody as Novel Therapeutic and Research Reagents for Alzheimer’s Disease.
- Generation and Characterization of Nanobodies Against beta-Amyloid
Research funding history
17 SBIR/STTR records share this UEI (2001–2018). Reported award amounts total $3,047,648. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services